Inspire Medical Systems (NYSE: INSP) reported Q3 EPS of ($0.38), $0.23 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $61.7 million versus the consensus estimate of $55.61 million.

GUIDANCE:

Inspire Medical Systems sees FY2021 revenue of $219-221 million, versus the consensus of $212 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.